Ossianix
PrivateLast Round
Grant
Jan 9, 2025
Total Funding Raised
$1.26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ossianix operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Grant round in January 2025.
Ossianix is a biotechnology company that provides a proprietary brain shuttle platform for the delivery of biotherapeutics across the Blood-Brain Barrier.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ossianix Comparables
Compare Ossianix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phragma Therapeutics | 85% | |
| NanoNewron, Inc. | 85% | |
| Aerska | 82% |
For institutional investors. Book with your work email.
Ossianix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 9, 2025 | ||||
| Strategic | Dec 16, 2014 | ||||
| Convertible Debt | Jan 3, 2012 |
For institutional investors. Book with your work email.
Ossianix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Convertible Debt, Seed |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
| BioAdvance Capital | Convertible Debt, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 130% MoM, reaching 2.5K.
- May 20, 2026
Monthly visitors grew 130% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Ossianix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ossianix's valuation, stock price, and market status.
Is Ossianix a public or private company?
Ossianix is a private company.
What is the current stock price of Ossianix?
Ossianix is a private company, so its shares have no public market price. Caplight tracks Ossianix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ossianix worth (valuation)?
Valuation information for Ossianix is not publicly available.
Can I buy Ossianix stock?
Ossianix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ossianix's last funding round?
Ossianix's most recent funding round was Grant on January 9, 2025.
Who are the main investors in Ossianix?
Key investors in Ossianix include The ALS Association, The Michael J. Fox Foundation for Parkinson's Research, BioAdvance Capital.
Will Ossianix IPO soon?
No public IPO plans have been announced for Ossianix.
How can I track Ossianix secondary market activity?
Caplight tracks bids, offers, and trades in Ossianix's shares on secondary markets.